The Current Ratio as of June 2026 (TTM) for Matinas BioPharma Holdings, Inc. (MTNB) is 1.32

According to Matinas BioPharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.32. This represents a change of -55.73% compared to the average of 2.99 of the last 4 quarters.

Matinas BioPharma Holdings, Inc. (MTNB) Historical Current Ratio (quarterly & annually)

How has MTNB Current Ratio performed in the past?

The mean historical Current Ratio of Matinas BioPharma Holdings, Inc. over the last ten years is 6.98. The current 1.32 Current Ratio has changed 1.80% with respect to the historical average. Over the past ten years (40 quarters), MTNB's Current Ratio was at its highest in in the March 2020 quarter at 29.10. The Current Ratio was at its lowest in in the June 2016 quarter at 0.58.

Matinas BioPharma Holdings, Inc. (MTNB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Matinas BioPharma Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Matinas BioPharma Holdings, Inc. (MTNB) Average Current Ratio

How has MTNB Current Ratio performed in the past?

The current Current Ratio of Matinas BioPharma Holdings, Inc. (MTNB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Matinas BioPharma Holdings, Inc. (MTNB) Current Ratio vs. Peers

How is MTNB’s Current Ratio compared to its peers?

Matinas BioPharma Holdings, Inc.’s Current Ratio is greater than Brainstorm Cell Therapeutics Inc. (0.02), greater than NeuroSense Therapeutics Ltd. (0.31), greater than Impact BioMedical Inc. (0.22), less than Addex Therapeutics Ltd (1.40), less than Adial Pharmaceuticals, Inc. (3.18), less than Cardio Diagnostics Holdings, Inc. (15.76), less than VYNE Therapeutics Inc. (20.86), greater than HCW Biologics Inc. (0.09), less than Pasithea Therapeutics Corp. (35.40), less than Acurx Pharmaceuticals, Inc. (3.78),

Build a custom stock screener for Matinas BioPharma Holdings, Inc. (MTNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Matinas BioPharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Matinas BioPharma Holdings, Inc. (MTNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Matinas BioPharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.